Beyond the Surface: Tailored Solutions for Tear Evaporation in Meibomian Gland Dysfunction

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, provide an overview of meibomian gland dysfunction (MGD) and its causes.

Dry eye specialists provide detailed insights on the differences between aqueous-deficient and evaporative dry eye disease.

Experts on dry eye describe the potential long-term consequences for patients if MGD is left untreated.

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO, discuss the first-line treatment of MGD, highlighting factors that inform treatment selection.

Experts provide clinical insights on the first FDA-approved treatment for evaporative dry eye, perfluorohexyloctane ophthalmic solution (MEIBO).

Selina McGee, OD, FAAO, discusses the role of cyclosporine ophthalmic solution (VEVYE) in the treatment of dry eye disease.

Dry eye experts provide comprehensive insights on the role of in-office procedural therapies.

Focusing on the care of patients with MGD, Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, provide key takeaways on treatment practices.